Cover ImageSALE
市場調查報告書

體外診斷 (IVD)的中國市場:2017∼2021年

IVD Market in China 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 331969
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷 (IVD)的中國市場:2017∼2021年 IVD Market in China 2017-2021
出版日期: 2017年05月10日 內容資訊: 英文 70 Pages
簡介

相對於體內檢驗在生物內進行,體外診斷 (IVD) 檢驗,在生物外的試管和培養皿、培養碟中進行。IVD,從患者身體採取血液和唾液,尿,髓液,DNA等生物樣本來進行。中國的IVD市場預計2017∼2021年以14.39%的年複合成長率擴大。

本報告提供中國的IVD市場相關調查,市場趨勢,2017∼2021年的成長預定,各市場區隔趨勢,及加入此市場的主要企業簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 中國的醫療結構

  • 中國家的醫療費用
  • 醫療改革
  • 中國的IVD產品的登記

第7章 各用途市場市場區隔

  • IVD市場區隔
  • 各用途市場市場區隔
  • 免疫化學
  • 血糖自我檢測(SMBG)
  • 分子診斷
  • 臨床微生物學
  • POC檢驗
  • 組織診斷
  • 血液學
  • 止血

第8章 各終端用戶市場區隔

  • 市場概要
  • 醫院
  • 居家照護
  • 研究機關
  • 獨立研究機關

第9章 決策結構

第10章 市場成長的促進要素與課題

第11章 市場趨勢

第12章 供應商環境

  • 競爭模式
  • 其他有潛力的供應商

第13章 主要供應商分析

  • Roche Diagnostics
  • Abbott
  • Siemens Healthineers
  • 值得注意的企業

第14章 附錄

  • 簡稱清單

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR13024

About In-vitro diagnostics (IVD)

IVD procedures are conducted outside of a living organism in a test tube, petri dish, or culture dish. Whereas, in vivo diagnostics are carried out inside a living organism. IVD products are intended to collect biological samples such as blood, sputum, urine, spinal fluid, and DNA from a patient's body. They are analyzed in hospitals, clinics, and laboratories. IVD products are reagents and instruments that help in the diagnosis of diseases.

Technavio's analysts forecast the in-vitro diagnostics (IVD) market in China to grow at a CAGR of 14.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of in-vitro diagnostics (IVD) market in China for 2017-2021. To calculate the market size, the report considers the new installations/shipments/sales/volume/value.

Technavio's report, In-vitro diagnostics (IVD) Market in China 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Roche Diagnostics
  • Abbott
  • Siemens Healthineers

Other Prominent Vendors

  • Atlas Link Biotech
  • Autobio Diagnostics
  • Bioneovan
  • Bioptik Technology
  • Bio-Rad Laboratories
  • Boson Biotech
  • C&G Biotech
  • Cepheid
  • Changchun Wancheng Bio-elect
  • Changsha City Epower Electronics & Science
  • Chongqing Haray International Business
  • Cusabio Biotech
  • Dako
  • Fudakang Ind'l
  • GE Healthcare
  • Grifols
  • Maya Medical Equipment Limited
  • Hologic
  • Illumina
  • Innovation Biotech
  • Intec Products
  • Jiangxi Zhongchenda Industrial Investment
  • Jiaxing Smir Medical Devices
  • Johnson & Johnson
  • Luminex
  • Nantong Egens Biotechnology
  • Nantong Voyage International Trade
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Quicking Biotech
  • Secure Detect
  • Shanghai Jiuyi International Trade
  • Shanghai Kehua Bio-Engineering
  • Shanghai Outdo Biotech
  • Shenzhen Fitconn Technology
  • Shiny Health Import & Export
  • Shenzhen New Industries Biomedical Engineering
  • Sunrising Enterprise
  • Wuhan HNC Technology
  • Yuan Yu Bio-Tech
  • Zhejiang Orient Gene Biotech

Market driver

  • Increase in incidences of chronic and infectious diseases
  • For a full, detailed list, view our report

Market challenge

  • Increase in demand and expectations of improved healthcare facilities
  • For a full, detailed list, view our report

Market trend

  • Companion diagnostics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01:Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Healthcare structure in China

  • Healthcare expenditure in China
  • Healthcare reforms
  • IVD product registration in China

PART 07: Market segmentation by application

  • IVD market segmentation
  • Market segmentation by application during the forecast period
  • Immunochemistry
  • SMBG
  • Molecular diagnostics
  • Clinical microbiology
  • POC testing
  • Tissue diagnostics
  • Hematology
  • Hemostasis

PART 08: Market segmentation by end-user

  • Market overview
  • Hospitals
  • Homecare
  • Research institutes
  • Independent laboratories

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Healthcare infrastructure expansion
  • Companion diagnostics
  • Continuous advances in IVD procedures

PART 12: Vendor landscape

  • Competitive landscape
  • Other prominent vendors

PART 13: Key vendor analysis

  • Roche Diagnostics
  • Abbott
  • Siemens Healthineers
  • Key companies to watch

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Involvement of diagnostics across the healthcare value chain of a person
  • Exhibit 02: Market analysis of IVD share in top five medical device segments
  • Exhibit 03: Types of IVD in China
  • Exhibit 04: IVD market in China 2016-2021 ($ millions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Healthcare expenditure per capita 2014 ($ millions)
  • Exhibit 07: Changes in healthcare reforms in China post 2009
  • Exhibit 08: Overview of IVD product registration in China
  • Exhibit 09: Segmentation of IVD market by application in 2016 (%)
  • Exhibit 10: Segmentation of IVD market by application in 2021 (%)
  • Exhibit 11: IVD market segmentation by application 2016-2021 ($ millions)
  • Exhibit 12: Immunochemistry market in China 2016-2021 ($ millions)
  • Exhibit 13: Market overview of immunochemistry in China 2016
  • Exhibit 14: SMBG market in China 2016-2021 ($ millions)
  • Exhibit 15: Market overview of SMBG in China 2016
  • Exhibit 16: Molecular diagnostics market in China 2016-2021 ($ millions)
  • Exhibit 17: Market overview of molecular diagnostics in China 2016
  • Exhibit 18: Clinical microbiology market in China 2016-2021 ($ millions)
  • Exhibit 19: Market overview of clinical microbiology in China 2016
  • Exhibit 20: POC testing market in China 2016-2021 ($ millions)
  • Exhibit 21: Market overview of POC testing in China 2016
  • Exhibit 22: Tissue diagnostics market in China 2016-2021 ($ millions)
  • Exhibit 23: Market overview of tissue diagnostics in China 2016
  • Exhibit 24: Hematology market in China 2016-2021 ($ millions)
  • Exhibit 25: Market overview of hematology in China 2016
  • Exhibit 26: Hemostasis market in China 2016-2021 ($ millions)
  • Exhibit 27: Market overview of hemostasis in China 2016
  • Exhibit 28: Hospitals in China
  • Exhibit 29: Segmentation of IVD market in China by end-users in 2016 (%)
  • Exhibit 30: Segmentation of IVD market in China by end-users in 2021 (%)
  • Exhibit 31: Market overview of end-user segment of IVD market in China 2016
  • Exhibit 32: Competitive structure analysis of IVD market in China
  • Exhibit 33: Market position of key vendors in China
  • Exhibit 34: Roche Diagnostics IVD division sales in 2016
  • Exhibit 35: Roche Diagnostics: Strength assessment
  • Exhibit 36: Roche Diagnostics: Strategy assessment
  • Exhibit 37: Roche Diagnostics: Opportunity assessment
  • Exhibit 38: Abbott: Strength assessment
  • Exhibit 39: Abbott: Strategy assessment
  • Exhibit 40: Abbott: Opportunity assessment
  • Exhibit 41: Siemens Healthineers: Strength assessment
  • Exhibit 42: Siemens Healthineers: Strategy assessment
  • Exhibit 43: Siemens Healthineers: Opportunity assessment
Back to Top